SINGAPORE, Sept. 20, 2011 /PRNewswire-Asia/ -- The high growth of
the biopharmaceutical market in Asia is creating a strong need for
production of biopharmaceuticals at higher qualities and volumes,
as well as developing an effective and efficient bioprocess. Over
the past few years, as upstream operations continue to improve, the
ability of current downstream facilities to handle the additional
load has led to strains and constrictions.
From a recent exclusive interview
with Sudip Kumar Majumder, Principal
Scientist at Intas Biopharmaceuticals India,
it is clear that innovations aimed at streamlining and redesigning
downstream processes will change the current state of play for the
biopharmaceutical industry.
Sudip Kumar Majumder will be
discussing on how you can re-design downstream processes
for better process economy and regulatory compliance at
the Downstream Bioprocessing & Single-Use Systems
Asia 2011conference.
Join leading experts at
Downstream Bioprocessing & Single-Use Systems Asia 2011 to
discuss bestpractices of process optimization and the
latest technologies in downstream bioprocessing.
Expert speakers from the downstream
bioprocessing space include:
*Visit www.downstreambioprocessing.com for the
full list of speakers.
Find out suitable technical
solutions and logical purification sequences to improve production
process performance, reduction of development time and thereby time
to market introduction.
Downstream Bioprocessing
& Single-Use Systems Asia 2011 will be held at
Amara Hotel, Singapore on 1 December 2011, together with a
post-conference workshop on 2 December 2011.
Drop an email to [email protected] to register for the
event or visit www.downstreambioprocesing.com for more
information.
SOURCE International Quality and
Productivity Center (IQPC Worldwide Pte Ltd)